Literature DB >> 12136262

The human false vocal folds -- an analysis of antimicrobial defense mechanisms.

Hannes Kutta1, Philipp Steven, Guido Kohla, Bernhard Tillmann, Friedrich Paulsen.   

Abstract

Inflammatory processes often lead to pathologic changes in the area of the larynx. A moistening function of the false vocal folds has been described frequently. Up to now we have little knowledge of the role of the false vocal folds in protection against pathogenic agents. The present study analyzes the structures of the false vocal folds in their relations to antimicrobial defense mechanisms. Investigations were performed on false vocal folds of larynges from 34 cadavers using histologic, histochemical and immunohistochemical methods. Seromucous glands, together with epithelial and goblet cells of the folds, synthesize a complex mucus layer. In all of the investigated samples this layer contains carbohydrates including N-acetyl-glucosamine, N-acetyl-galactosamine, galactose, mannose, fucose, and sialic acids. Furthermore, antimicrobial peptides like lactoferrin, lysozyme, alpha and beta defensins are also found in these structures. IgA, produced by plasma cells in the false vocal folds, is frequently integrated in the secretory product. Synthesized mucins, antimicrobial peptides and immunoglobulins form a specialized protective substance that is secreted mainly at the true vocal folds. Here the layer functions to lubricate the true vocal folds, resulting in positive functional consequences during vocal production. Moreover, together with immunocompetent cells, the protective layer seems to play a major role in antigen defense and prevents invasion of pathogenic agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136262     DOI: 10.1007/s00429-002-0255-8

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  13 in total

Review 1.  Vocal fold epithelial barrier in health and injury: a research review.

Authors:  Elizabeth Erickson Levendoski; Ciara Leydon; Susan L Thibeault
Journal:  J Speech Lang Hear Res       Date:  2014-10       Impact factor: 2.297

Review 2.  [Functional anatomy of the larynx from clinical points of view: part II: Laryngeal mucous membrane, blood supply, innervation, lymphatic drainage, age-related changes].

Authors:  H Kutta; S Knipping; H Claassen; F Paulsen
Journal:  HNO       Date:  2007-08       Impact factor: 1.284

3.  Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region.

Authors:  Hannes Kutta; Andreas Willer; Philipp Steven; Lars Bräuer; Michael Tsokos; Friedrich Paulsen
Journal:  J Anat       Date:  2008-07-22       Impact factor: 2.610

4.  On the acoustic effects of the supraglottic structures in excised larynges.

Authors:  Fariborz Alipour; Eileen Finnegan
Journal:  J Acoust Soc Am       Date:  2013-05       Impact factor: 1.840

Review 5.  Defensins as anti-inflammatory compounds and mucosal adjuvants.

Authors:  Karl G Kohlgraf; Lindsey C Pingel; Deborah E Dietrich; Kim A Brogden
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

6.  The role of glottal surface adhesion on vocal folds biomechanics.

Authors:  Pinaki Bhattacharya; Thomas Siegmund
Journal:  Biomech Model Mechanobiol       Date:  2014-07-18

7.  Laryngeal T regulatory cells in the setting of smoking and reflux.

Authors:  Marie E Jetté; Christine M Seroogy; Susan L Thibeault
Journal:  Laryngoscope       Date:  2016-09-22       Impact factor: 3.325

8.  Muscular anatomy of the human ventricular folds.

Authors:  Jerald Moon; Fariborz Alipour
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-09       Impact factor: 1.547

9.  Vocal fold ion transport and mucin expression following acrolein exposure.

Authors:  Elizabeth Erickson Levendoski; M Preeti Sivasankar
Journal:  J Membr Biol       Date:  2014-03-20       Impact factor: 1.843

10.  Epithelial cells are active participants in vocal fold wound healing: an in vivo animal model of injury.

Authors:  Ciara Leydon; Mitsuyoshi Imaizumi; Rebecca S Bartlett; Sarah F Wang; Susan L Thibeault
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.